FIELD: chemical; pharmaceutical industry and medicine; neurology.
SUBSTANCE: anxiolytic, sedative and anti-stress agent is proposed in the form of a tablet oral form, containing as an active principle a combination of alimemazine tartrate and ethylmethylhydroxypyridine succinate, as excipients microcrystalline cellulose, povidone K25, croscarmellose sodium, talc and magnesium stearate at a certain content of components.
EFFECT: anxiolytic, sedative and anti-stress medicinal product and a method of its obtaining.
2 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION HAVING NEUROPROTECTIVE ACTIVITY IN CHRONIC CEREBRAL ISCHEMIA | 2023 |
|
RU2816359C1 |
| METHOD FOR PRODUCTION OF ANTIOXIDANT PREPARATION IN FORM OF TABLET | 2020 |
|
RU2749718C1 |
| MODIFIED RELEASE 6-METHYL-2-ETHYL-HYDROXYPYRIDINE SUCCINATE DOSAGE FORM | 2008 |
|
RU2411035C2 |
| SYSTEM FOR DELIVERY OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION IN FORM OF GASTRORETENTIVE TABLET | 2019 |
|
RU2734970C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALIMAMAZINE TARTRATE | 2017 |
|
RU2659200C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE | 2021 |
|
RU2798106C1 |
| PHARMACEUTICAL COMPOSITION FOR SLEEP DISORDERS PREVENTION AND TREATMENT | 2016 |
|
RU2620855C1 |
| DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
| PHARMACEUTICAL COMPOSITION OF FABOMOTIZOLE DIHYDROCHLORIDE | 2022 |
|
RU2828872C2 |
| PHARMACEUTIC COMBINATION OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE AND PYRIDOXINE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2405552C2 |
